AstraZeneca

Improving Treatment for Dyslipidemia

Working with Queen’s University, Remedy developed a series of one-page summaries to answer a number of clinical questions regarding issues in the management of dyslipidemia that would in turn lead to improved care in this suboptimally treated-patient group.